Sign in
RGBP Stock Price, Chart, Stats & News
Regen BioPharma, Inc.
Save
Regen BioPharma, Inc. (RGBP) does not currently pay a dividend.
3,155
Market cap
–
Current P/E
–
Forward P/E
RGBP chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions.
Similar securities
Based on sector and market capitalization
Report issue